| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 2 securities · passive | ||||||
|
AEON Biopharma, Inc.
13G
AEON · 00791X209
|
13.0% |
8/21/2026
Event 8/19/2026
|
||||
|
Evolus, Inc.
13G/A
EOLS · 30052C107
|
9.9% |
2/17/2026
Event 12/31/2025
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.